Tri-Ion™ Chemistry
Innovation through Tri Ion™ Chemistry
Because confidence matters when conditions are unpredictable. Non-sterile environments may dictate unpredictable conditions and outcomes.
Proteomics
The Future of Antimicrobial Technology
Where antibiotics and antimicrobials fail and bacteria adapt, engineered chemistries involving carrier molecules to deliver superior antimicrobial and antiviral power—maintaining activity in high-protein environments including whole blood where conventional solutions cannot.
Confidence changes Protocols
At Spectrum Antimicrobials, we’re not just developing new treatments; we’re pioneering chemistries that will end the era of antibiotic-resistant infections and redefine how the world controls, prevents and treats infection.
Consistency reduces downstream cost
Our breakthrough discoveries provide healthcare professionals with proprietary, tissue‑selective drug candidates and solutions designed to improve the control, prevention, and treatment of infection. Our research focuses on addressing critical unmet needs across wound care, deep tissue infection, respiratory, and ophthalmic applications—improving clinical outcomes while reducing overall healthcare costs.
Hand Hygiene
Fewer variables. Fewer interventions. Designed to perform where alcohol‑based chemistries may fail to eradicate all viruses and bacteria. The product complies with EN 1500 testing requirements. Spectricept™ Hand Sanitizer has demonstrated a 15‑second kill rate against *Clostridioides difficile*. Spectricept™ Hand Sanitizer is approved for use in NHS hospitals in the United Kingdom.
Wound Care
Precision matters when conditions are unpredictable. Spectricept™ Skin and Wound Cleanser Rx incorporates Tri‑Ion™ Chemistry, demonstrating consistent preservative performance in the presence of 5% whole blood. Not all HOCl solutions are engineered with tissue specificity and safety management. Tri‑Ion™ Chemistry is intended for use only within its cleared indications.
Pulmonary & Respiratory Infections
Innovative approaches for managing infections in challenging biological environments such as the upper and lower respiratory tract, where mucus and contaminants can limit conventional treatments. Drug candidate SPC‑P2 is designed to provide sustained antimicrobial and antiviral activity in high‑mucus environments to effectively reduce bacterial and viral burden.
<Drag or scroll to explore >
Predictability is a clinical advantage
Our composition of chemistries are distinct and tissue selective. We combine stability, broad-spectrum efficacy, and safety in ways no existing therapeutics can match:
Get in Touch for More Information
If you have any questions or need further details about our infection care solutions, feel free to reach out. We’re here to assist you in improving patient outcomes.
By submitting this form, you agree to our Terms and Conditions.